Repurposing Therapeutic Drugs for COVID-19: Research Challenges and Opportunities | NLM

Disaster Information Management Research Center | NLM

Repurposing Therapeutic Drugs for COVID-19: Research Challenges and Opportunities

06/19/2020 12:00 AM EDT

Source: U.S. House of Representatives, Committee on Science, Space, and Technology. Published: 6/19/2020. This one-hour, 27-minute Congressional hearing revolves around one of the most promising tools in the public health response to the COVID-19 pandemic: repurposing existing therapeutic drugs to treat COVID-19. In the absence of any COVID-19 vaccine or novel treatment, existing therapeutics could potentially offer critical assistance for severely ill patients and bridge the gap until more prevention and treatment options become available. (Video or Multimedia)